Akari Therapeutics Plc Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Akari Therapeutics Plc quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2011 to Q2 2024.
  • Akari Therapeutics Plc Retained Earnings (Accumulated Deficit) for the quarter ending June 30, 2024 was -$42.7M, a 80.6% increase year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 -$42.7M +$178M +80.6% Jun 30, 2024 8-K 2024-09-06
Q1 2024 -$233M Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$38.2M -$12.8M -50.6% Dec 31, 2023 8-K 2024-09-06
Q2 2023 -$220M -$9.89M -4.7% Jun 30, 2023 6-K 2023-09-29
Q4 2022 -$25.3M +$174M +87.3% Dec 31, 2022 8-K 2024-09-06
Q2 2022 -$211M -$18.1M -9.4% Jun 30, 2022 6-K 2022-09-27
Q4 2021 -$200M -$17.4M -9.56% Dec 31, 2021 20-F 2023-05-01
Q2 2021 -$192M -$16.1M -9.12% Jun 30, 2021 6-K 2021-09-22
Q4 2020 -$182M -$17.1M -10.3% Dec 31, 2020 20-F 2022-05-16
Q3 2020 -$175M -$18.1M -11.5% Sep 30, 2020 20-F 2021-04-21
Q2 2020 -$176M -$21.9M -14.2% Jun 30, 2020 20-F 2021-04-21
Q1 2020 -$169M -$20.4M -13.7% Mar 31, 2020 20-F 2021-04-21
Q4 2019 -$165M -$38.4M -30.3% Dec 31, 2019 20-F 2021-04-21
Q3 2019 -$157M Sep 30, 2019 20-F 2021-04-21
Q2 2019 -$154M -$34.8M -29.1% Jun 30, 2019 20-F 2021-04-21
Q1 2019 -$149M Mar 31, 2019 20-F 2021-04-21
Q4 2018 -$127M -$16.5M -14.9% Dec 31, 2018 20-F 2020-03-31
Q2 2018 -$120M -$31.9M -36.3% Jun 30, 2018 6-K 2018-09-27
Q4 2017 -$110M -$35.4M -47.2% Dec 31, 2017 20-F 2019-04-23
Q2 2017 -$87.8M -$21.6M -32.6% Jun 30, 2017 6-K 2017-08-10
Q4 2016 -$74.9M -$18.1M -31.9% Dec 31, 2016 20-F 2018-07-18
Q2 2016 -$66.2M -$32.1M -93.8% Jun 30, 2016 6-K/A 2017-04-14
Q1 2016 -$59.8M -$27.3M -83.9% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 -$56.8M -$45.3M -395% Dec 31, 2015 6-K/A 2017-04-14
Q3 2015 -$63.3M Sep 30, 2015 10-Q 2015-11-23
Q2 2015 -$34.2M Jun 30, 2015 10-Q 2015-08-12
Q1 2015 -$32.5M Mar 31, 2015 10-Q 2015-05-12
Q4 2014 -$11.5M +$9.06M +44.1% Dec 31, 2014 10-K 2016-03-23
Q4 2013 -$20.5M -$3.62M -21.4% Dec 31, 2013 10-K 2015-02-11
Q4 2012 -$16.9M -$4.3M -34.1% Dec 31, 2012 20-F 2014-03-24
Q4 2011 -$12.6M Dec 31, 2011 20-F/A 2013-04-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.